State funds trial of psilocybin-assisted psychotherapy
May 16, 2023
State funds trial of psilocybin-assisted psychotherapy
Psychiatrists at the University of Washington School of Medicine are designing a trial to study the medical use of psilocybin, after Washington legislators passed a law that authorized the research.
"What we're anticipating is studying people who are veterans or first-responders, who meet diagnostic criteria for PTSD, post-traumatic stress disorder, (and) who also meet diagnostic criteria for alcohol-use disorder," said Dr. Nathan Sackett, acting assistant professor in psychiatry & behavioral sciences.
The trial is expected to start by Jan. 1, 2025. In a blog post, learn more about the trial and its impetus.
News reporters and news organizations may freely republish and distribute videos, still images and audio files produced by UW Medicine and the University of Washington School of Medicine.
Works must be attributed/credited appropriately (for example, “UW Medicine” – as denoted in the file) and must not be used for commercial purposes.
These visual and audio files may not be used to exploit or misrepresent UW Medicine or the University of Washington.
UW Medicine often licenses still images and stock video from Getty Images, but we cannot grant republishing rights. You may not republish single image files, videos or animations credited to Getty Images.
Logos of UW Medicine and University of Washington Health Sciences schools may not be republished without explicit permission. Contact us by phone or email: 206.543.3620 or mediarelations@uw.edu